Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

U. Platzbecker; H. K. Al-Ali; N. Gattermann; D. Haase; V. Janzen; J. Krauter; K. Götze; R. Schlenk; F. Nolte; A. Letsch; O. G. Ottmann; A. Kündgen; M. Lübbert; U. Germing; M. Wermke; H. Reinhard; C. Weiss; K. Lieder; G. Ehninger; O. Leismann; A. Giagounidis

doi:10.1038/leu.2013.325

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

U. Platzbecker, H. K. Al-Ali, N. Gattermann, D. Haase, V. Janzen, J. Krauter, K. Götze, R. Schlenk, F. Nolte, A. Letsch, O. G. Ottmann, A. Kündgen, M. Lübbert, U. Germing, M. Wermke, H. Reinhard, C. Weiss, K. Lieder, G. Ehninger, O. LeismannA. Giagounidis

Department of Internal Medicine III - Hematology and Medical Oncology

Research output: Contribution to journal › Letter › peer-review

20 Scopus citations

Original language	English
Pages (from-to)	696-698
Number of pages	3
Journal	Leukemia
Volume	28
Issue number	3
DOIs	https://doi.org/10.1038/leu.2013.325
State	Published - Mar 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2013.325

Cite this

Platzbecker, U., Al-Ali, H. K., Gattermann, N., Haase, D., Janzen, V., Krauter, J., Götze, K., Schlenk, R., Nolte, F., Letsch, A., Ottmann, O. G., Kündgen, A., Lübbert, M., Germing, U., Wermke, M., Reinhard, H., Weiss, C., Lieder, K., Ehninger, G., ... Giagounidis, A. (2014). Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients. Leukemia, 28(3), 696-698. https://doi.org/10.1038/leu.2013.325

@article{fe920d70a98b4d2f9151f762cb439f02,

title = "Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients",

author = "U. Platzbecker and Al-Ali, {H. K.} and N. Gattermann and D. Haase and V. Janzen and J. Krauter and K. G{\"o}tze and R. Schlenk and F. Nolte and A. Letsch and Ottmann, {O. G.} and A. K{\"u}ndgen and M. L{\"u}bbert and U. Germing and M. Wermke and H. Reinhard and C. Weiss and K. Lieder and G. Ehninger and O. Leismann and A. Giagounidis",

year = "2014",

month = mar,

doi = "10.1038/leu.2013.325",

language = "English",

volume = "28",

pages = "696--698",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "3",

}

Platzbecker, U, Al-Ali, HK, Gattermann, N, Haase, D, Janzen, V, Krauter, J, Götze, K, Schlenk, R, Nolte, F, Letsch, A, Ottmann, OG, Kündgen, A, Lübbert, M, Germing, U, Wermke, M, Reinhard, H, Weiss, C, Lieder, K, Ehninger, G, Leismann, O & Giagounidis, A 2014, 'Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients', Leukemia, vol. 28, no. 3, pp. 696-698. https://doi.org/10.1038/leu.2013.325

TY - JOUR

T1 - Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

AU - Platzbecker, U.

AU - Al-Ali, H. K.

AU - Gattermann, N.

AU - Haase, D.

AU - Janzen, V.

AU - Krauter, J.

AU - Götze, K.

AU - Schlenk, R.

AU - Nolte, F.

AU - Letsch, A.

AU - Ottmann, O. G.

AU - Kündgen, A.

AU - Lübbert, M.

AU - Germing, U.

AU - Wermke, M.

AU - Reinhard, H.

AU - Weiss, C.

AU - Lieder, K.

AU - Ehninger, G.

AU - Leismann, O.

AU - Giagounidis, A.

PY - 2014/3

Y1 - 2014/3

UR - http://www.scopus.com/inward/record.url?scp=84895817174&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.325

DO - 10.1038/leu.2013.325

M3 - Letter

C2 - 24186004

AN - SCOPUS:84895817174

SN - 0887-6924

VL - 28

SP - 696

EP - 698

JO - Leukemia

JF - Leukemia

IS - 3

ER -

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients

UN SDGs

Access to Document

Other files and links

Cite this